| Application no. and date | 02749660.3 (espacenet) (Federated) (European Patent Register), 20020625 | | Patent/reg. no. and date | DK/EP 1409016, 20100414 | | Publication date | 20040421 | | Priority no. and date | US 301172 P, 20010626 | | EP pub. no. and date |
EP 1409016 20040421 | | Effective date | | | Applicant/owner | Amgen Inc., One Amgen Center Drive
Thousand Oaks, CA 91320-1799, US,
Amgen Fremont Inc., One Amgen Center Drive
Thousand Oaks, CA 91320-1799, US | | Applicant ref. no. | V49533DK00 | | Inventor | MARTIN, Francis, H., 865 Fernhill Court
Newbury Park, CA 91320, US,
CORVALAN, Jose, R., 125 Williams Lane
Foster City, CA 94404, US,
DAVIS, Geoffrey, C., 1132 Vancouver Avenue
Burlingame, CA 94010, US,
BOYLE, William, J., 25362 Malibu Road, 2
Malibu, CA 90265, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61P 19/08 (2006.01) , C07K 16/28 (2006.01) , G01N 33/53 (2006.01) | | Title | Antistoffer mod OPGL | | Int. application no. | US2002020181 | | Int. publication no. | WO2003002713 | | Related patent (certificate) | CA 2010 00031 | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
